FDC Limited (NSE:FDC)

Market Cap	54.89B -16.5%
Revenue (ttm)	20.78B -0.0%
Net Income	2.17B -21.0%
EPS	13.30 -20.5%
Shares Out	n/a
PE Ratio	25.33
Forward PE	n/a
Dividend	5.00 (1.42%)
Ex-Dividend Date	Feb 11, 2026

Volume	211,383
Average Volume	80,946
Open	341.80
Previous Close	340.55
Day's Range	331.00 - 348.00
52-Week Range	331.00 - 527.80
Beta	-0.06
RSI	31.93
Earnings Date	May 27, 2026

About FDC Limited

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1936
• Employees: 6,857
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: FDC

Financial Performance

In fiscal year 2025, FDC Limited's revenue was 21.08 billion, an increase of 8.50% compared to the previous year's 19.43 billion. Earnings were 2.67 billion, a decrease of -12.59%.